Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 49Thoracic 9Gastrointestinal 8Head & Neck 7Gynecologic 6Genitourinary 6Breast 5Sarcoma 3Other hematologic neoplasm 2Lymphoid 2CNS 2Plasma cell 1Other neoplasm 1NET 1Endocrine 1

Conditions

Precancerous Conditions 12Uterine Cervical Neoplasms 3Uterine Cervical Dysplasia 3Esophageal Neoplasms 2Uterine Neoplasms 1Uterine Diseases 1Uterine Cervical Diseases 1Urogenital Neoplasms 1Urogenital Diseases 1Tongue Neoplasms 1Squamous Intraepithelial Lesions 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Oropharyngeal Neoplasms 1Neoplasms by Site 1Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Neoplasms 1Myelodysplastic Syndromes 1Mouth Neoplasms 1Monoclonal Gammopathy of Undetermined Significance 1Melanoma 1Lymphoid Interstitial Pneumonia 1Lung Neoplasms 1Leukoplakia, Oral 1Laryngeal Neoplasms 1Keratosis, Actinic 1

Interventions

tremelimumab 1Watchful Waiting 1Ribavirin 1Lovastatin 1Infliximab 1Chromatography, High Pressure Liquid 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Melanoma × Biopsy × Other neoplasm × Clear all
NCT00462280 2014-10-31

Lovastatin in Treating Patients At High Risk of Melanoma

National Cancer Institute (NCI)

Phase 2 Completed
80 enrolled 35 charts
DermatologicOther neoplasm

Melanoma, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡